PUNE, India, April 5, 2017 /PRNewswire/ --
According to a new market research report "Active Implantable Medical Devices Market by Product (Implantable Cardioverter Defibrillators (Transvenous & Subcutaneous), Cardiac Pacemaker, Ventricular Assist Device, Neurostimulator, Implantable Hearing Devices) - Global Forecast to 2022", published by MarketsandMarkets™, the market witnessed healthy growth during the last decade and is expected to grow at a CAGR of 7.8% between 2017 and 2022 to reach USD 26.75 Billion by 2022.
(Logo: http://photos.prnewswire.com/prnh/20160303/792302 )
Browse 151 market data Tables and 34 Figures spread through 204 Pages and in-depth TOC on "Active Implantable Medical Devices Market"
http://www.marketsandmarkets.com/Market-Reports/active-implantable-medical-devices-market-102063992.html
Early buyers will receive 10% customization on this report.
Growth in this market can be attributed to factors such as growth in aging population, increasing prevalence of cardiovascular and neurological diseases, investments and funds to develop technologically advanced products, expanded applications of neurostimulators, and favorable reimbursement scenario for ENT procedures in developed countries.
The global Active Implantable Medical Devices Market is segmented based on product and region. Based on product, the market is segmented into implantable cardioverter defibrillators, implantable cardiac pacemakers, implantable heart monitors/insertable loop recorders, ventricular assist devices, neurostimulators, and implantable hearing devices.
Download PDF Brochure: http://www.marketsandmarkets.com/pdfdownload.asp?id=102063992
Based on region, the Active Implantable Medical Devices Market is segmented into North America, Europe, Asia-Pacific, Latin America, and the Middle East and Africa.
In 2016, the implantable cardioverter defibrillators segment accounted for the largest share of the global Active Implantable Medical Devices Market. However, the implantable hearing devices segment is expected to witness the highest growth in the next five years. The growth of the implantable hearing devices is mainly attributed to the increasing prevalence of hearing loss across the globe and growing ENT procedures due to favorable reimbursement policies in the developed countries.
North America is the largest regional segment for the Active Implantable Medical Devices Market. The large share of this regional segment can be attributed to the growth in geriatric population, increasing prevalence of cardiovascular and neurological diseases, high accessibility to advanced technologies, increasing development of innovative and technologically advanced products, and increasing healthcare expenditure in the region.
Talk To Our Research Analysts: http://www.marketsandmarkets.com/speaktoanalyst.asp?id=102063992
However, the Active Implantable Medical Devices Market in the Asia-Pacific region is expected to grow at the highest CAGR, owing to the growth in geriatric population, growing incidence of chronic diseases, rising healthcare spending, healthcare reforms for infrastructural development, growing demand for advanced technologies to develop advanced products, and less stringent regulations.
Medtronic plc (Ireland), Abbott Laboratories (U.S.), and Boston Scientific Corporation (U.S.) held the major share of the implantable cardiovascular and neurostimulators devices market. Whereas, Cochlear Limited (Australia), MED-EL (Austria), Sonova Holding AG (Switzerland), and William Demant Holding A/S (Denmark) held the major share of the implantable hearing devices market. These players will continue to dominate the market between 2017 and 2022. Other major players operating in the implantable cardiovascular and neurostimulators devices market are BIOTRONIK SE & Co. KG (Germany) and LivaNova PLC (U.K.). Nurotron Biotechnology Co. Ltd. (China) and Medtronic plc (Ireland) are the other key players in the implantable hearing devices market.
Browse Related Reports:
DEFIBRILLATORS MARKET By Product (Implantable Cardioverter Defibrillator (Transvenous ICD, Single & Dual Chamber, CRT-D, S-ICD) and External (Manual, AED, Wearable)), End User (Hospital, Prehospital, Public Access, Home) - Global Forecasts to 2021.
http://www.marketsandmarkets.com/Market-Reports/automated-external-defibrillator-market-549.html
ENT DEVICES MARKET By Product (Diagnostic (Endoscope (Rigid, Flexible), Hearing Screening), Surgical (RF, Handheld (Otology & Laryngeal), Packing Material, Ear Tubes), Hearing Aids, Lasers), & End User (Hospital & Ambulatory) - Global Forecast to 2020.
http://www.marketsandmarkets.com/Market-Reports/ent-devices-market-150060281.html
About MarketsandMarkets:
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies' revenues. Currently servicing 5000 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.
Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model - GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, and strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.
MarketsandMarkets's flagship competitive intelligence and market research platform, "RT" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.
Contact: Mr. Rohan MarketsandMarkets™ 701 Pike Street Suite 2175, Seattle, WA 98101, United States Tel: 1-888-600-6441 Email: [email protected]
Visit our Blog @ http://mnmblog.org/market-research/healthcare/medical-devices
Connect with us on LinkedIn @ http://www.linkedin.com/company/marketsandmarkets
SOURCE MarketsandMarkets
Advertisement
According to a new market research report "Active Implantable Medical Devices Market by Product (Implantable Cardioverter Defibrillators (Transvenous & Subcutaneous), Cardiac Pacemaker, Ventricular Assist Device, Neurostimulator, Implantable Hearing Devices) - Global Forecast to 2022", published by MarketsandMarkets™, the market witnessed healthy growth during the last decade and is expected to grow at a CAGR of 7.8% between 2017 and 2022 to reach USD 26.75 Billion by 2022.
Advertisement
(Logo: http://photos.prnewswire.com/prnh/20160303/792302 )
Browse 151 market data Tables and 34 Figures spread through 204 Pages and in-depth TOC on "Active Implantable Medical Devices Market"
http://www.marketsandmarkets.com/Market-Reports/active-implantable-medical-devices-market-102063992.html
Early buyers will receive 10% customization on this report.
Growth in this market can be attributed to factors such as growth in aging population, increasing prevalence of cardiovascular and neurological diseases, investments and funds to develop technologically advanced products, expanded applications of neurostimulators, and favorable reimbursement scenario for ENT procedures in developed countries.
The global Active Implantable Medical Devices Market is segmented based on product and region. Based on product, the market is segmented into implantable cardioverter defibrillators, implantable cardiac pacemakers, implantable heart monitors/insertable loop recorders, ventricular assist devices, neurostimulators, and implantable hearing devices.
Download PDF Brochure: http://www.marketsandmarkets.com/pdfdownload.asp?id=102063992
Based on region, the Active Implantable Medical Devices Market is segmented into North America, Europe, Asia-Pacific, Latin America, and the Middle East and Africa.
In 2016, the implantable cardioverter defibrillators segment accounted for the largest share of the global Active Implantable Medical Devices Market. However, the implantable hearing devices segment is expected to witness the highest growth in the next five years. The growth of the implantable hearing devices is mainly attributed to the increasing prevalence of hearing loss across the globe and growing ENT procedures due to favorable reimbursement policies in the developed countries.
North America is the largest regional segment for the Active Implantable Medical Devices Market. The large share of this regional segment can be attributed to the growth in geriatric population, increasing prevalence of cardiovascular and neurological diseases, high accessibility to advanced technologies, increasing development of innovative and technologically advanced products, and increasing healthcare expenditure in the region.
Talk To Our Research Analysts: http://www.marketsandmarkets.com/speaktoanalyst.asp?id=102063992
However, the Active Implantable Medical Devices Market in the Asia-Pacific region is expected to grow at the highest CAGR, owing to the growth in geriatric population, growing incidence of chronic diseases, rising healthcare spending, healthcare reforms for infrastructural development, growing demand for advanced technologies to develop advanced products, and less stringent regulations.
Medtronic plc (Ireland), Abbott Laboratories (U.S.), and Boston Scientific Corporation (U.S.) held the major share of the implantable cardiovascular and neurostimulators devices market. Whereas, Cochlear Limited (Australia), MED-EL (Austria), Sonova Holding AG (Switzerland), and William Demant Holding A/S (Denmark) held the major share of the implantable hearing devices market. These players will continue to dominate the market between 2017 and 2022. Other major players operating in the implantable cardiovascular and neurostimulators devices market are BIOTRONIK SE & Co. KG (Germany) and LivaNova PLC (U.K.). Nurotron Biotechnology Co. Ltd. (China) and Medtronic plc (Ireland) are the other key players in the implantable hearing devices market.
Browse Related Reports:
DEFIBRILLATORS MARKET By Product (Implantable Cardioverter Defibrillator (Transvenous ICD, Single & Dual Chamber, CRT-D, S-ICD) and External (Manual, AED, Wearable)), End User (Hospital, Prehospital, Public Access, Home) - Global Forecasts to 2021.
http://www.marketsandmarkets.com/Market-Reports/automated-external-defibrillator-market-549.html
ENT DEVICES MARKET By Product (Diagnostic (Endoscope (Rigid, Flexible), Hearing Screening), Surgical (RF, Handheld (Otology & Laryngeal), Packing Material, Ear Tubes), Hearing Aids, Lasers), & End User (Hospital & Ambulatory) - Global Forecast to 2020.
http://www.marketsandmarkets.com/Market-Reports/ent-devices-market-150060281.html
About MarketsandMarkets:
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies' revenues. Currently servicing 5000 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.
Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model - GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, and strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.
MarketsandMarkets's flagship competitive intelligence and market research platform, "RT" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.
Contact: Mr. Rohan MarketsandMarkets™ 701 Pike Street Suite 2175, Seattle, WA 98101, United States Tel: 1-888-600-6441 Email: [email protected]
Visit our Blog @ http://mnmblog.org/market-research/healthcare/medical-devices
Connect with us on LinkedIn @ http://www.linkedin.com/company/marketsandmarkets
SOURCE MarketsandMarkets
